Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.

Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R.

J Neuroimmunol. 2006 Mar;172(1-2):27-37. Epub 2005 Dec 7.

PMID:
16337691
2.

Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.

Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, Richardson J, Willson TM, Weinberg G, Feinstein DL.

J Neuroimmunol. 2005 Nov;168(1-2):65-75. Epub 2005 Aug 10.

PMID:
16098614
3.

A neuroprotective derivative of erythropoietin that is not erythropoietic.

Doggrell SA.

Expert Opin Investig Drugs. 2004 Nov;13(11):1517-9.

PMID:
15500399
4.

Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis.

Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR.

J Neurosci. 2006 Jun 21;26(25):6823-33.

5.

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P.

Brain Res. 2002 Oct 11;952(1):128-34.

PMID:
12363412
6.

High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).

Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjørn SE, Gerwien J, Leist M.

Thromb Haemost. 2008 Apr;99(4):720-8. doi: 10.1160/TH07-03-0208.

PMID:
18392330
7.

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.

J Neuroimmunol. 2004 Mar;148(1-2):146-53.

PMID:
14975595
8.

Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.

Mengozzi M, Cervellini I, Bigini P, Martone S, Biondi A, Pedotti R, Gallo B, Barbera S, Mennini T, Boraso M, Marinovich M, Petit E, Bernaudin M, Bianchi R, Viviani B, Ghezzi P.

Mol Med. 2008 Nov-Dec;14(11-12):682-8. doi: 10.2119/2008-00086.Mengozzi. Epub 2008 Jul 30.

9.

Anti-inflammatory effect of erythropoietin therapy on experimental autoimmune encephalomyelitis.

Zhang X, Li QY, Xiao BG.

Int J Neurosci. 2012 May;122(5):255-62. doi: 10.3109/00207454.2011.648761. Epub 2012 Feb 6.

PMID:
22176555
10.

Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.

Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y.

J Neuroimmunol. 2008 Feb;194(1-2):107-14. doi: 10.1016/j.jneuroim.2007.12.001. Epub 2008 Jan 22.

PMID:
18207251
11.

Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.

King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT.

Eur J Neurosci. 2007 Jul;26(1):90-100.

PMID:
17614942
12.

Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.

Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK.

Clin Exp Immunol. 2010 Nov;162(2):210-23.

13.

Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.

Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q.

J Neuroimmunol. 2009 Jan 3;206(1-2):58-69. doi: 10.1016/j.jneuroim.2008.10.014. Epub 2008 Dec 9.

PMID:
19081144
14.

Derivatives of erythropoietin that are tissue protective but not erythropoietic.

Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M.

Science. 2004 Jul 9;305(5681):239-42.

15.

Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.

Genoud S, Maricic I, Kumar V, Gage FH.

J Neuroimmunol. 2005 Nov;168(1-2):40-5. Epub 2005 Aug 24.

PMID:
16120466
16.

Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.

Dutra RC, de Souza PR, Bento AF, Marcon R, Bicca MA, Pianowski LF, Calixto JB.

Biochem Pharmacol. 2012 Feb 15;83(4):531-42. doi: 10.1016/j.bcp.2011.11.026. Epub 2011 Dec 1.

PMID:
22155310
17.

Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.

Hu X, Qin X.

Int J Mol Med. 2013 May;31(5):1209-21. doi: 10.3892/ijmm.2013.1306. Epub 2013 Mar 15.

PMID:
23525227
18.

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.

Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L.

J Immunol. 1999 Sep 1;163(5):2403-9.

19.

Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?

Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S.

Int J Urol. 2008 Oct;15(11):1011-7. doi: 10.1111/j.1442-2042.2008.02149.x. Epub 2008 Aug 26.

20.

The effect of Am-80, one of retinoids derivatives on experimental allergic encephalomyelitis in rats.

Wang T, Niwa S, Bouda K, Matsuura S, Homma T, Shudo K, Nagai H.

Life Sci. 2000 Sep 1;67(15):1869-79.

PMID:
11043609

Supplemental Content

Support Center